Metraipolis › archive › dc_2161bbbfec3c

Real-World Evidence of Upadacitinib Effectiveness in Moderate to Severe Atopic Dermatitis Patients in Saudi Arabia: A Retrospective Chart Review — Europe PMC PMID:42466098

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42466098
DOI: 10.1155/drp/1238540
License (as archived): solo-consultazione
Archived: 2026-10-18T06:32:41.023Z
SHA-256 of the archived text: dba24261455f84fb2b83100d609e9b18b8db1b2ecdf13f5845d1b0fa096968cf
Stable URL of this page: https://metraipolis.com/documento/dc_2161bbbfec3c

How to cite

Real-World Evidence of Upadacitinib Effectiveness in Moderate to Severe Atopic Dermatitis Patients in Saudi Arabia: A Retrospective Chart Review — Europe PMC PMID:42466098 — Europe PMC (en), https://europepmc.org/article/MED/42466098 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2161bbbfec3c (Metraipolis archive dc_2161bbbfec3c, sha256 dba24261455f84fb2b83100d609e9b18b8db1b2ecdf13f5845d1b0fa096968cf)

BibTeX

@misc{dc2161bbbfec3c,
  title = {Real-World Evidence of Upadacitinib Effectiveness in Moderate to Severe Atopic Dermatitis Patients in Saudi Arabia: A Retrospective Chart Review — Europe PMC PMID:42466098},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42466098},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2161bbbfec3c; sha256 dba24261455f84fb2b83100d609e9b18b8db1b2ecdf13f5845d1b0fa096968cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42466098. Agents can read the archived copy with the MCP tool read_document.